Skip to main content
FinSpry Logo
FinSpry
QGEN logo
QGEN
(NYSE)
Qiagen N.V.
$41.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Qiagen (QGEN) Stock Price & Financial Analysis

Qiagen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$39.36 - $40.72
52-Week High$57.82
52-Week Low$32.53
Open$39.54
Volume2.07M
Average Volume (3M)2.87M
Market Cap8.47B
Shares Outstanding208.94M
P/E Ratio (TTM)21.57
Forward P/E10.73
Price to Sales (P/S)4.13
Price to Book (P/B)2.60
EV/EBITDA13.93
Revenue (TTM)2.10B
Net Income (TTM)402.17M
Free Cash Flow (TTM)410.54M
EPS (TTM)$1.93
Profit Margin19.16%
Operating Margin25.91%
Return on Equity (ROE)12.07%
Debt to Equity0.49
50-Day MA$37.10
200-Day MA$44.17
52-Week Change-13.95%
Annual Dividend$4.70
Dividend Yield11.32%
Payout Ratio200.00%
Last Dividend Ex-DateJul 7, 2026

Frequently Asked Questions About Qiagen

What is the current stock price for QGEN?

As of the latest trading session, QGEN stock trades at $40.53. The 52-week range is $32.53–$57.82, with a day range of $39.36–$40.72.

What is the P/E ratio for QGEN?

Qiagen's trailing P/E ratio is 21.6, meaning investors pay $21.6 for every $1 of annual earnings. The forward P/E is 10.7, reflecting analyst expectations for future earnings. Qiagen operates in the Healthcare sector.

Does QGEN pay dividends?

Yes, Qiagen pays a 11.32% annual dividend yield ($4.70 per share). The payout ratio is 200.0%. The last ex-dividend date was 2026-07-07.

What do analysts recommend for QGEN?

Based on 15 analysts, the consensus for QGEN is Hold.

What is the market cap of QGEN?

Qiagen's market capitalization is $8.47B, classifying it as a mid-cap company. Qiagen operates in the Healthcare sector within the Diagnostics & Research industry.